Loading...
NPI 1689633711 · Bellaire, TX · Clinical Pathology/Laboratory Medicine Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Kevin Rosenblatt is a clinical pathology/laboratory medicine physician provider located in Bellaire, Texas. This profile covers 5 Medicare and 18 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Kevin Rosenblatt |
| Address | 4800 Fournace Pl Ste Be13 |
| City | Bellaire |
| State | TX |
| ZIP | 77401 |
| Taxonomy | Clinical Pathology/Laboratory Medicine Physician |
| NPI Enumerated | March 18, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $836.8K |
| Medicaid | $18.5K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80505 | At the request of a physician or other qualified healthcare provider, the pathologist performs a consultation for a highly complex clinical problem requiring a high level of medical judgment to help… | 5,750 | $70 | $414.2K |
| 80506 | At the request of a physician or other qualified healthcare provider, the pathologist performs a consultation. If the pathologist documents spending at least 75 minutes on the consultation date, you… | 12,500 | $30 | $412.5K |
| 80504 | At the request of a physician or other qualified healthcare provider, the pathologist performs a consultation for a moderately complex clinical problem requiring a moderate level of medical judgment… | 130 | $40 | $5.3K |
| G0452 | Molecular pathology procedure; physician interpretation and report | 20 | $30 | $530 |
| 99451 | A consulting physician or other qualified healthcare professional performs a 5–minute or more consult via telephone, internet, or electronic health record (EHR) and provides a written report to the… | 10 | $20 | $230 |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 5 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
18 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 81479 | Use 81479 to report a molecular pathology procedure that does not have a specific code. | 70 | $240 | $17.4K |
| 81225 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for cytochrome P450, family 2, subfamily C, polypeptide 19, also known as CYP2C19. | 30 | $20 | $440 |
| 81401 | The lab analyst performs the technical lab test to complete one of the specific genetic analyses listed in this Tier 2, Level 2 molecular pathology code. | 10 | $10 | $100 |
| 81291 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for 5,10–methylenetetrahydrofolate reductase, also known as MTHFR. | 30 | $1 | $80 |
| 81350 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for UDP glucuronosyltransferase 1 family, polypeptide A1, also known as UGT1A1. | 10 | $10 | $80 |
| 81355 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for vitamin K epoxide reductase complex, subunit 1, also known as VKORC1. | 10 | $10 | $60 |
| 81226 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for cytochrome P450, family 2, subfamily D, polypeptide 6, also known as CYP2D6. | 30 | $1 | $60 |
| 81227 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for cytochrome P450, family 2, subfamily C, polypeptide 9, also known as CYP2C9. | 30 | $1 | $60 |
| 81240 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for prothrombin, coagulation factor II, also known as F2. | 10 | $1 | $40 |
| 81241 | The lab analyst performs the technical lab test to detect the presence of a common change, called the Leiden variant, in the gene for coagulation factor V, also known as Factor V Leiden or F5. | 10 | $1 | $40 |
Showing 1–10 of 18
How this provider's Medicaid billing volume and revenue compare to other Texas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Texas median
18 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 81401 | The lab analyst performs the technical lab test to complete one of the specific genetic analyses listed in this Tier 2, Level 2 molecular pathology code. | 40 | 40 | 140 | $20 | $20.2K |
| 81479 | Use 81479 to report a molecular pathology procedure that does not have a specific code. | 10 | 20 | 70 | $10 | $5.7K |
| 81226 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for cytochrome P450, family 2, subfamily D, polypeptide 6, also known as CYP2D6. | 24 | 30 | 50 | $20 | $3.8K |
| 81241 | The lab analyst performs the technical lab test to detect the presence of a common change, called the Leiden variant, in the gene for coagulation factor V, also known as Factor V Leiden or F5. | 31 | 30 | 80 | $10 | $3.5K |
| 81225 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for cytochrome P450, family 2, subfamily C, polypeptide 19, also known as CYP2C19. | 25 | 40 | 50 | $20 | $2.8K |
| 81240 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for prothrombin, coagulation factor II, also known as F2. | 27 | 30 | 90 | $10 | $2.6K |
| 81291 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for 5,10–methylenetetrahydrofolate reductase, also known as MTHFR. | 23 | 30 | 50 | $10 | $1.6K |
| 81227 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for cytochrome P450, family 2, subfamily C, polypeptide 9, also known as CYP2C9. | 17 | 30 | 40 | $10 | $1.4K |
| 81328 | The lab analyst performs the technical lab test to detect the presence of specific changes in the solute carrier organic anion transporter family, member 1B1 (SLCO1B) gene for common variants, such… | 21 | 20 | 70 | $10 | $1.1K |
| 81355 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for vitamin K epoxide reductase complex, subunit 1, also known as VKORC1. | 22 | 20 | 30 | $1 | $640 |
Showing 1–10 of 18
Other providers in the same ZIP code as Kevin Rosenblatt, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Kingsley Home Care Inc | TX | Home Health Agency | $0 | $22.7M |
| Charles Wykoff | TX | Ophthalmology Physician | $6.2M | $0 |
| Matthew Benz | TX | Ophthalmology Physician | $5.7M | $0 |
| Adaku Iwu | TX | Family Nurse Practitioner | $3.3M | $0 |
| Rishabh Date | TX | Ophthalmology Physician | $2.9M | $0 |
| Emmanuel Chang | TX | Retina Specialist (Ophthalmology) Physician | $2.2M | $0 |
| Arash Kimyai-asadi | TX | MOHS-Micrographic Surgery Physician | $2.2M | $0 |
| Leonard Goldberg | TX | MOHS-Micrographic Surgery Physician | $2.1M | $0 |
| Paul Stewart | TX | Retina Specialist (Ophthalmology) Physician | $2.1M | $0 |
| Effie Rahman | TX | Ophthalmology Physician | $2M | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.